Parexel International Office
Biotechnology Company
Why pick this one
Parexel International Office supports biopharmaceutical development from portfolio optimization through Phase I-IV clinical trials, regulatory strategy, and market access planning.
Best for
- biopharmaceutical companies needing integrated clinical development
- early-phase clinical trials and proof-of-concept planning
- portfolio optimization and asset valuation
- regulatory strategy and approval planning
- market access and value substantiation planning
- clinical programs requiring study start-up or medical affairs support
Specialties
- portfolio optimization and asset valuation
- early phase clinical trials
- integrated Phase I-IV clinical development
- regulatory strategy
- real world evidence
- market access planning
- medical affairs
- study start-up
What makes them different
- Offers end-to-end development solutions spanning portfolio optimization, regulatory strategy, Phase I-IV clinical trials, and market access planning
- Combines clinical, regulatory, and market access strategies for portfolio and asset valuation
- Provides a multidisciplinary early-phase approach integrating study design, clinical evidence generation, and development-phase planning
- Offers ParexelAI, FSP Integrated Solutions, operational excellence, medical affairs, and study start-up capabilities
Distilled from this business's own website.
Contact & Location
- Address
- 2520 Meridian Pkwy, Durham, NC 27713-4202
- Phone
- +17814879900
- Website
- http://www.parexel.com/
Services
- clinical research organization services
- biopharmaceutical development services
- clinical trial services
- regulatory services
- market access services
- portfolio management
- value substantiation lifecycle management